10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EKSO (Ekso Bionics Holdings Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Ekso Bionics Holdings Inc together

I guess you are interested in Ekso Bionics Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Ekso Bionics Holdings Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Ekso Bionics Holdings Inc’s Price Targets

I'm going to help you getting a better view of Ekso Bionics Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Ekso Bionics Holdings Inc

I send you an email if I find something interesting about Ekso Bionics Holdings Inc.

1. Quick Overview

1.1. Quick analysis of Ekso Bionics Holdings Inc (30 sec.)










1.2. What can you expect buying and holding a share of Ekso Bionics Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$0.50
Expected worth in 1 year
$0.19
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.30
Return On Investment
-8.8%

For what price can you sell your share?

Current Price per Share
$3.38
Expected price per share
$2.73 - $5.157
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ekso Bionics Holdings Inc (5 min.)




Live pricePrice per Share (EOD)
$3.38
Intrinsic Value Per Share
$-21.86 - $21.34
Total Value Per Share
$-21.36 - $21.84

2.2. Growth of Ekso Bionics Holdings Inc (5 min.)




Is Ekso Bionics Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$12.6m$14.9m-$1.8m-14.1%

How much money is Ekso Bionics Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.6m-$3.5m$861.5k31.9%
Net Profit Margin-62.9%-80.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Ekso Bionics Holdings Inc (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#129 / 159

Most Revenue
#131 / 159

Most Profit
#113 / 159

Most Efficient
#136 / 159
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ekso Bionics Holdings Inc?

Welcome investor! Ekso Bionics Holdings Inc's management wants to use your money to grow the business. In return you get a share of Ekso Bionics Holdings Inc.

First you should know what it really means to hold a share of Ekso Bionics Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of Ekso Bionics Holdings Inc is $3.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ekso Bionics Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ekso Bionics Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.50. Based on the TTM, the Book Value Change Per Share is $-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ekso Bionics Holdings Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.11-3.4%-0.12-3.6%-0.24-7.2%-0.21-6.4%-0.30-8.7%-1.26-37.2%
Usd Book Value Change Per Share-0.02-0.5%-0.08-2.3%-0.20-5.9%-0.18-5.3%-0.02-0.6%-0.19-5.6%
Usd Dividend Per Share0.010.3%0.000.1%0.000.0%0.000.0%0.000.0%0.113.3%
Usd Total Gains Per Share-0.01-0.2%-0.07-2.2%-0.20-5.9%-0.18-5.2%-0.02-0.6%-0.08-2.3%
Usd Price Per Share0.40-0.81-1.51-1.28-2.82-2.44-
Price to Earnings Ratio-0.88--1.70--1.61--1.56--2.46--1.28-
Price-to-Total Gains Ratio-57.71--12.83--10.15--9.75--11.73--5.58-
Price to Book Ratio0.81-1.29-1.58-1.21--92.11--45.58-
Price-to-Total Gains Ratio-57.71--12.83--10.15--9.75--11.73--5.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.38
Number of shares295
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.08-0.02
Usd Total Gains Per Share-0.07-0.02
Gains per Quarter (295 shares)-21.97-5.78
Gains per Year (295 shares)-87.89-23.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13-91-981-24-33
25-181-1861-47-56
38-272-2742-71-79
411-362-3622-95-102
513-453-4503-118-125
616-543-5383-142-148
718-634-6264-166-171
821-724-7144-189-194
924-815-8025-213-217
1026-905-8905-237-240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%3.037.00.07.5%5.047.00.09.6%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%3.017.00.015.0%10.030.00.025.0%15.037.00.028.8%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.019.05.0%3.00.037.07.5%4.00.048.07.7%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%3.017.00.015.0%11.029.00.027.5%16.036.00.030.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Ekso Bionics Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.016-0.077+383%-0.199+1150%-0.178+1018%-0.020+26%-0.189+1091%
Book Value Per Share--0.5000.602-17%1.017-51%1.222-59%1.594-69%2.253-78%
Current Ratio--2.3462.518-7%2.648-11%3.314-29%4.758-51%3.655-36%
Debt To Asset Ratio--0.5350.526+2%0.516+4%0.455+18%0.456+17%0.576-7%
Debt To Equity Ratio--1.1521.113+4%1.077+7%0.897+28%0.892+29%1.867-38%
Dividend Per Share--0.0090.002+300%-+100%0.001+1100%0.000+1900%0.111-92%
Enterprise Value---4384621.0007723174.750-157%16744814.750-126%18687009.833-123%38290512.400-111%21509285.704-120%
Eps---0.114-0.122+7%-0.242+113%-0.215+89%-0.295+159%-1.257+1004%
Ev To Ebitda Ratio--0.319-1.098+445%-1.447+554%-1.671+625%-3.624+1237%-1.994+726%
Ev To Sales Ratio---0.3250.406-180%0.939-135%1.193-127%3.454-109%2.042-116%
Free Cash Flow Per Share---0.077-0.099+28%-0.192+148%-0.191+147%-0.228+195%-1.118+1345%
Free Cash Flow To Equity Per Share--0.062-0.013+121%-0.134+317%-0.141+328%0.181-66%0.045+38%
Gross Profit Margin--1.5901.689-6%1.578+1%1.628-2%1.561+2%1.211+31%
Intrinsic Value_10Y_max--21.341----------
Intrinsic Value_10Y_min---21.859----------
Intrinsic Value_1Y_max---0.344----------
Intrinsic Value_1Y_min---4.111----------
Intrinsic Value_3Y_max--0.859----------
Intrinsic Value_3Y_min---10.761----------
Intrinsic Value_5Y_max--4.342----------
Intrinsic Value_5Y_min---15.618----------
Market Cap7999344.600-28%10233379.00017012424.750-40%22405314.750-54%19743259.833-48%31936062.400-68%19202935.704-47%
Net Profit Margin---0.857-0.629-27%-0.801-6%-0.800-7%-1.075+25%-1.782+108%
Operating Margin---0.878-0.623-29%-0.788-10%-0.807-8%-1.068+22%-1.709+95%
Operating Ratio--2.0191.642+23%1.781+13%1.838+10%2.012+0%2.905-30%
Pb Ratio6.762+88%0.8061.292-38%1.581-49%1.210-33%-92.113+11524%-45.578+5753%
Pe Ratio-7.422-739%-0.885-1.704+93%-1.614+82%-1.564+77%-2.464+178%-1.285+45%
Price Per Share3.380+88%0.4030.807-50%1.506-73%1.275-68%2.821-86%2.439-83%
Price To Free Cash Flow Ratio-10.920-739%-1.302-2.066+59%-2.417+86%-1.954+50%-3.236+149%-1.806+39%
Price To Total Gains Ratio-484.012-739%-57.709-12.835-78%-10.147-82%-9.754-83%-11.728-80%-5.584-90%
Quick Ratio--0.7551.555-51%1.896-60%2.518-70%4.086-82%3.107-76%
Return On Assets---0.106-0.099-7%-0.115+9%-0.101-5%-0.106+0%-0.173+64%
Return On Equity---0.228-0.209-8%-0.239+5%-0.194-15%-0.167-27%-0.554+143%
Total Gains Per Share---0.007-0.074+967%-0.199+2743%-0.177+2432%-0.020+181%-0.078+1016%
Usd Book Value--12692000.00013082000.000-3%14930250.000-15%18259750.000-30%21138100.000-40%14707275.000-14%
Usd Book Value Change Per Share---0.016-0.077+383%-0.199+1150%-0.178+1018%-0.020+26%-0.189+1091%
Usd Book Value Per Share--0.5000.602-17%1.017-51%1.222-59%1.594-69%2.253-78%
Usd Dividend Per Share--0.0090.002+300%-+100%0.001+1100%0.000+1900%0.111-92%
Usd Enterprise Value---4384621.0007723174.750-157%16744814.750-126%18687009.833-123%38290512.400-111%21509285.704-120%
Usd Eps---0.114-0.122+7%-0.242+113%-0.215+89%-0.295+159%-1.257+1004%
Usd Free Cash Flow---1965000.000-2093500.000+7%-2857250.000+45%-2880000.000+47%-2850700.000+45%-4255775.000+117%
Usd Free Cash Flow Per Share---0.077-0.099+28%-0.192+148%-0.191+147%-0.228+195%-1.118+1345%
Usd Free Cash Flow To Equity Per Share--0.062-0.013+121%-0.134+317%-0.141+328%0.181-66%0.045+38%
Usd Market Cap7999344.600-28%10233379.00017012424.750-40%22405314.750-54%19743259.833-48%31936062.400-68%19202935.704-47%
Usd Price Per Share3.380+88%0.4030.807-50%1.506-73%1.275-68%2.821-86%2.439-83%
Usd Profit---2891000.000-2698000.000-7%-3559500.000+23%-3246750.000+12%-3350950.000+16%-4418675.000+53%
Usd Revenue--3375000.0004386000.000-23%4478250.000-25%4160333.333-19%3557600.000-5%3160325.000+7%
Usd Total Gains Per Share---0.007-0.074+967%-0.199+2743%-0.177+2432%-0.020+181%-0.078+1016%
 EOD+3 -5MRQTTM+16 -24YOY+20 -203Y+17 -235Y+18 -2210Y+23 -17

3.3 Fundamental Score

Let's check the fundamental score of Ekso Bionics Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.422
Price to Book Ratio (EOD)Between0-16.762
Net Profit Margin (MRQ)Greater than0-0.857
Operating Margin (MRQ)Greater than0-0.878
Quick Ratio (MRQ)Greater than10.755
Current Ratio (MRQ)Greater than12.346
Debt to Asset Ratio (MRQ)Less than10.535
Debt to Equity Ratio (MRQ)Less than11.152
Return on Equity (MRQ)Greater than0.15-0.228
Return on Assets (MRQ)Greater than0.05-0.106
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Ekso Bionics Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.175
Ma 20Greater thanMa 503.424
Ma 50Greater thanMa 1004.574
Ma 100Greater thanMa 2005.625
OpenGreater thanClose3.410
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Ekso Bionics Holdings Inc

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Fundamental data was last updated by Penke on 2025-07-11 02:13:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Ekso Bionics Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Ekso Bionics Holdings Inc to theΒ Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -85.7%Β means thatΒ $-0.86 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ekso Bionics Holdings Inc:

  • The MRQ is -85.7%. The company is making a huge loss. -2
  • The TTM is -62.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-85.7%TTM-62.9%-22.7%
TTM-62.9%YOY-80.1%+17.2%
TTM-62.9%5Y-107.5%+44.6%
5Y-107.5%10Y-178.2%+70.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-85.7%5.0%-90.7%
TTM-62.9%4.7%-67.6%
YOY-80.1%6.5%-86.6%
3Y-80.0%6.4%-86.4%
5Y-107.5%6.1%-113.6%
10Y-178.2%6.6%-184.8%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Ekso Bionics Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Ekso Bionics Holdings Inc to theΒ Medical Instruments & Supplies industry mean.
  • -10.6% Return on Assets means thatΒ Ekso Bionics Holdings Inc generatedΒ $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ekso Bionics Holdings Inc:

  • The MRQ is -10.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.6%TTM-9.9%-0.7%
TTM-9.9%YOY-11.5%+1.7%
TTM-9.9%5Y-10.6%+0.8%
5Y-10.6%10Y-17.3%+6.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.6%1.0%-11.6%
TTM-9.9%1.0%-10.9%
YOY-11.5%1.0%-12.5%
3Y-10.1%1.2%-11.3%
5Y-10.6%1.5%-12.1%
10Y-17.3%1.5%-18.8%
4.3.1.3. Return on Equity

Shows how efficient Ekso Bionics Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Ekso Bionics Holdings Inc to theΒ Medical Instruments & Supplies industry mean.
  • -22.8% Return on Equity means Ekso Bionics Holdings Inc generated $-0.23Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ekso Bionics Holdings Inc:

  • The MRQ is -22.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.8%TTM-20.9%-1.9%
TTM-20.9%YOY-23.9%+3.0%
TTM-20.9%5Y-16.7%-4.2%
5Y-16.7%10Y-55.4%+38.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.8%2.2%-25.0%
TTM-20.9%1.9%-22.8%
YOY-23.9%1.8%-25.7%
3Y-19.4%2.1%-21.5%
5Y-16.7%3.0%-19.7%
10Y-55.4%2.9%-58.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Ekso Bionics Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Ekso Bionics Holdings Inc is operatingΒ .

  • Measures how much profit Ekso Bionics Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Ekso Bionics Holdings Inc to theΒ Medical Instruments & Supplies industry mean.
  • An Operating Margin of -87.8%Β means the company generated $-0.88 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ekso Bionics Holdings Inc:

  • The MRQ is -87.8%. The company is operating very inefficient. -2
  • The TTM is -62.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-87.8%TTM-62.3%-25.5%
TTM-62.3%YOY-78.8%+16.4%
TTM-62.3%5Y-106.8%+44.5%
5Y-106.8%10Y-170.9%+64.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-87.8%8.0%-95.8%
TTM-62.3%6.0%-68.3%
YOY-78.8%6.0%-84.8%
3Y-80.7%6.7%-87.4%
5Y-106.8%8.7%-115.5%
10Y-170.9%9.0%-179.9%
4.3.2.2. Operating Ratio

Measures how efficient Ekso Bionics Holdings Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 2.02 means that the operating costs are $2.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 2.019. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.642. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.019TTM1.642+0.377
TTM1.642YOY1.781-0.139
TTM1.6425Y2.012-0.370
5Y2.01210Y2.905-0.892
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0191.168+0.851
TTM1.6421.131+0.511
YOY1.7811.023+0.758
3Y1.8381.084+0.754
5Y2.0121.053+0.959
10Y2.9051.016+1.889
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Ekso Bionics Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ekso Bionics Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.35Β means the company has $2.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 2.346. The company is able to pay all its short-term debts. +1
  • The TTM is 2.518. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.346TTM2.518-0.172
TTM2.518YOY2.648-0.129
TTM2.5185Y4.758-2.240
5Y4.75810Y3.655+1.103
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3462.053+0.293
TTM2.5182.039+0.479
YOY2.6482.318+0.330
3Y3.3142.380+0.934
5Y4.7582.609+2.149
10Y3.6552.576+1.079
4.4.3.2. Quick Ratio

Measures if Ekso Bionics Holdings Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Ekso Bionics Holdings Inc to theΒ Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.75Β means the company can pay off $0.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 0.755. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.555. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.755TTM1.555-0.800
TTM1.555YOY1.896-0.341
TTM1.5555Y4.086-2.531
5Y4.08610Y3.107+0.978
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7550.835-0.080
TTM1.5550.948+0.607
YOY1.8961.090+0.806
3Y2.5181.201+1.317
5Y4.0861.425+2.661
10Y3.1071.556+1.551
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Ekso Bionics Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Ekso Bionics Holdings IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Ekso Bionics Holdings Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.54Β means that Ekso Bionics Holdings Inc assets areΒ financed with 53.5% credit (debt) and the remaining percentage (100% - 53.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 0.535. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.526. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.535TTM0.526+0.010
TTM0.526YOY0.516+0.009
TTM0.5265Y0.456+0.069
5Y0.45610Y0.576-0.119
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5350.395+0.140
TTM0.5260.384+0.142
YOY0.5160.357+0.159
3Y0.4550.350+0.105
5Y0.4560.357+0.099
10Y0.5760.374+0.202
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Ekso Bionics Holdings Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Ekso Bionics Holdings Inc to theΒ Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 115.2% means that company has $1.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 1.152. The company is able to pay all its debts with equity. +1
  • The TTM is 1.113. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.152TTM1.113+0.039
TTM1.113YOY1.077+0.036
TTM1.1135Y0.892+0.221
5Y0.89210Y1.867-0.975
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1520.606+0.546
TTM1.1130.591+0.522
YOY1.0770.558+0.519
3Y0.8970.580+0.317
5Y0.8920.574+0.318
10Y1.8670.664+1.203
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Ekso Bionics Holdings Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Ekso Bionics Holdings Inc to theΒ Medical Instruments & Supplies industry mean.
  • A PE ratio of -0.88 means the investor is paying $-0.88Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ekso Bionics Holdings Inc:

  • The EOD is -7.422. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.885. Based on the earnings, the company is expensive. -2
  • The TTM is -1.704. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.422MRQ-0.885-6.537
MRQ-0.885TTM-1.704+0.820
TTM-1.704YOY-1.614-0.091
TTM-1.7045Y-2.464+0.760
5Y-2.46410Y-1.285-1.180
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-7.42215.617-23.039
MRQ-0.88514.950-15.835
TTM-1.70414.998-16.702
YOY-1.61417.237-18.851
3Y-1.56418.333-19.897
5Y-2.46420.650-23.114
10Y-1.28520.725-22.010
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ekso Bionics Holdings Inc:

  • The EOD is -10.920. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.302. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.066. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.920MRQ-1.302-9.618
MRQ-1.302TTM-2.066+0.764
TTM-2.066YOY-2.417+0.351
TTM-2.0665Y-3.236+1.170
5Y-3.23610Y-1.806-1.430
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-10.9209.966-20.886
MRQ-1.3029.091-10.393
TTM-2.0669.766-11.832
YOY-2.4179.099-11.516
3Y-1.9544.559-6.513
5Y-3.2365.094-8.330
10Y-1.8061.765-3.571
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Ekso Bionics Holdings Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 0.81 means the investor is paying $0.81Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ekso Bionics Holdings Inc:

  • The EOD is 6.762. Based on the equity, the company is overpriced. -1
  • The MRQ is 0.806. Based on the equity, the company is cheap. +2
  • The TTM is 1.292. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD6.762MRQ0.806+5.956
MRQ0.806TTM1.292-0.486
TTM1.292YOY1.581-0.289
TTM1.2925Y-92.113+93.405
5Y-92.11310Y-45.578-46.536
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD6.7622.454+4.308
MRQ0.8062.397-1.591
TTM1.2922.562-1.270
YOY1.5812.695-1.114
3Y1.2102.743-1.533
5Y-92.1133.519-95.632
10Y-45.5783.925-49.503
4.6.2. Total Gains per Share

2.4. Latest News of Ekso Bionics Holdings Inc

Does Ekso Bionics Holdings Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Ekso Bionics Holdings Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-18
13:30
Ekso Bionics’ Acceptance into NVIDIA Connect Program Bears Early FruitRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ekso Bionics Holdings Inc.

4.8.1. Institutions holding Ekso Bionics Holdings Inc

Institutions are holding 10.728% of the shares of Ekso Bionics Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Armistice Capital, LLC5.75320.0123204238231673318.3544
2025-03-31Vanguard Group Inc1.67230593648-779-0.1311
2025-03-31Cresset Asset Management, LLC0.75910.0005269474-30526-10.1753
2025-03-31Geode Capital Management, LLC0.560601990203508021.3981
2025-03-31Citadel Advisors Llc0.504101789471789470
2025-03-31State Street Corp0.39040138580115400497.843
2025-03-31Renaissance Technologies Corp0.23130.00018211662008.1669
2025-03-31BlackRock Inc0.154205474900
2025-03-31FNY Investment Advisers, LLC0.14790.012852500525000
2025-03-31Compagnie Lombard, Odier SCA0.07040.00012500000
2025-03-31Northern Trust Corp0.0702485000
2025-03-31Virtu Financial LLC0.06730.000523905239050
2025-03-31Golden State Wealth Management, LLC0.05490.00121950500
2025-03-31HRT FINANCIAL LLC0.0481017082365527.2213
2025-03-31TWO SIGMA SECURITIES, LLC0.04750.00116853168530
2025-03-31IFP Advisors, LLC0.04230.000215000150000
2025-03-31Two Sigma Investments LLC0.0305010817108170
2025-03-31RESOURCES MANAGEMENT CORP /CT/ /ADV0.02820.000610000100000
2025-03-31Tower Research Capital LLC0.01810.00016415-47-0.7273
2025-03-31UBS Group AG0.0041014391285834.4156
Total 10.65450.02943782282+755023+20.0%

4.9.2. Funds holding Ekso Bionics Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31Vanguard Total Stock Mkt Idx Inv1.1293040088700
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr0.50550.000117945500
2025-04-30Fidelity Extended Market Index0.36060.0002128013-1223-0.9463
2024-12-31World Impact SICAV Imptt Glbl Eq IEURAcc0.12120.03034301200
2025-04-30Fidelity Series Total Market Index0.08803125600
2025-04-30Spartan Extended Market Index Pool F0.0430.00011525812238.7139
2025-04-30Fidelity Total Market Index0.041801483800
2024-12-31Vanguard Instl Ttl Stck Mkt Idx Tr0.039701408500
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.03420.00011213300
2025-03-31Northern Trust Extended Eq Market Idx0.03240.00011150700
2025-03-31NT Ext Equity Mkt Idx Fd - L0.03240.00011150700
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02660.00019445-172-1.7885
2025-04-30Spartan Total Market Index Pool G0.01990705000
2025-03-31Extended Equity Market Fund K0.016705943180.3038
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00780.00012764220.8023
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.00770.0001274227420
2025-05-31State St US Extended Mkt Indx NL Cl C0.0050177300
2025-05-31State St US Ttl Mkt Indx NL Cl A0.00420150000
2025-03-31Northern Trust Wilshire 50000.00340121000
2025-03-31Extended Equity Market Fund M0.00210744-25-3.251
Total 2.52150.0313895122+2585+0.3%

5.3. Insider Transactions

Insiders are holding 5.497% of the shares of Ekso Bionics Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-17Jerome WongSELL56225
2023-08-17Scott G DavisSELL166225
2023-05-24Steven ShermanSELL202324
2023-05-08Jason C JonesSELL15353.25
2022-12-04Steven ShermanSELL47288
2022-11-16Jason C JonesSELL3288
2022-11-16Jerome WongSELL3288
2022-10-24Steven ShermanSELL26290.25
2022-09-22Steven ShermanSELL26393.75
2022-08-22Steven ShermanSELL24495
2022-08-03Jerome WongSELL7405
2022-07-25Steven ShermanSELL25393.75
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Depreciation and Amortization  406-939710407-9398-875-477



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets27,310
Total Liabilities14,618
Total Stockholder Equity12,692
 As reported
Total Liabilities 14,618
Total Stockholder Equity+ 12,692
Total Assets = 27,310

Assets

Total Assets27,310
Total Current Assets20,068
Long-term Assets7,242
Total Current Assets
Cash And Cash Equivalents 8,054
Net Receivables 6,457
Inventory 4,962
Total Current Assets  (as reported)20,068
Total Current Assets  (calculated)19,473
+/- 595
Long-term Assets
Property Plant Equipment 2,137
Goodwill 431
Intangible Assets 4,317
Long-term Assets Other 357
Long-term Assets  (as reported)7,242
Long-term Assets  (calculated)7,242
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,553
Long-term Liabilities6,065
Total Stockholder Equity12,692
Total Current Liabilities
Short-term Debt 1,675
Short Long Term Debt 1,250
Accounts payable 1,999
Other Current Liabilities 2,966
Total Current Liabilities  (as reported)8,553
Total Current Liabilities  (calculated)7,890
+/- 663
Long-term Liabilities
Long term Debt 3,597
Capital Lease Obligations 770
Long-term Liabilities Other 164
Long-term Liabilities  (as reported)6,065
Long-term Liabilities  (calculated)4,531
+/- 1,534
Total Stockholder Equity
Common Stock28
Retained Earnings -253,592
Accumulated Other Comprehensive Income 424
Other Stockholders Equity 265,832
Total Stockholder Equity (as reported)12,692
Total Stockholder Equity (calculated)12,692
+/-0
Other
Capital Stock28
Common Stock Shares Outstanding 25,393
Current Deferred Revenue1,913
Liabilities and Stockholders Equity 27,310
Net Debt 5,617
Net Invested Capital 17,539
Net Working Capital 11,515
Property Plant and Equipment Gross 2,137
Short Long Term Debt Total 5,617



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-30
> Total Assets 
5
13
30
29
2
0
0
21,801
18,598
15,418
33,474
30,033
26,906
22,126
32,198
22,551
13,575
21,621
24,425
16,895
18,932
43,405
37,988
30,959
23,208
22,423
17,655
20,860
25,583
20,292
21,915
16,944
22,349
23,486
20,597
56,504
52,973
50,733
49,166
44,242
40,520
39,311
40,903
37,104
33,986
31,183
28,918
28,957
26,984
29,209
26,652
27,310
27,31026,65229,20926,98428,95728,91831,18333,98637,10440,90339,31140,52044,24249,16650,73352,97356,50420,59723,48622,34916,94421,91520,29225,58320,86017,65522,42323,20830,95937,98843,40518,93216,89524,42521,62113,57522,55132,19822,12626,90630,03333,47415,41818,59821,8010022930135
   > Total Current Assets 
5
13
30
29
2
0
0
18,856
15,306
11,662
29,300
25,550
22,182
17,248
25,201
18,221
9,367
17,574
20,684
13,262
15,301
40,168
34,937
27,937
20,403
19,853
14,967
16,835
22,133
17,034
18,807
14,062
19,910
21,549
18,420
54,605
51,295
49,099
47,795
43,123
39,323
36,754
31,037
27,597
24,720
22,362
20,208
20,516
18,642
21,066
18,843
20,068
20,06818,84321,06618,64220,51620,20822,36224,72027,59731,03736,75439,32343,12347,79549,09951,29554,60518,42021,54919,91014,06218,80717,03422,13316,83514,96719,85320,40327,93734,93740,16815,30113,26220,68417,5749,36718,22125,20117,24822,18225,55029,30011,66215,30618,8560022930135
       Cash And Cash Equivalents 
5
13
30
29
2
0
0
14,576
10,965
7,176
25,190
21,133
16,251
11,238
19,552
12,314
4,661
12,800
16,846
9,426
10,701
33,439
27,813
20,572
13,890
12,995
7,655
9,236
13,262
8,058
10,872
8,516
13,260
14,549
12,862
49,539
45,938
43,439
40,406
36,176
31,912
29,180
20,525
16,277
13,307
9,937
8,638
8,799
5,885
8,292
6,493
8,054
8,0546,4938,2925,8858,7998,6389,93713,30716,27720,52529,18031,91236,17640,40643,43945,93849,53912,86214,54913,2608,51610,8728,05813,2629,2367,65512,99513,89020,57227,81333,43910,7019,42616,84612,8004,66112,31419,55211,23816,25121,13325,1907,17610,96514,5760022930135
       Short-term Investments 
0
0
0
0
3,477
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000003,4770000
       Net Receivables 
0
0
0
0
0
0
0
1,775
1,494
1,922
1,549
1,455
2,394
2,185
2,069
2,383
1,606
2,234
1,780
1,282
2,107
2,168
2,760
3,574
3,547
2,988
3,660
3,793
4,541
5,206
5,208
2,658
3,741
4,450
3,389
2,276
2,756
3,121
4,662
3,346
3,341
3,398
4,625
4,827
5,052
5,873
5,645
5,773
6,520
6,964
7,238
6,457
6,4577,2386,9646,5205,7735,6455,8735,0524,8274,6253,3983,3413,3464,6623,1212,7562,2763,3894,4503,7412,6585,2085,2064,5413,7933,6602,9883,5473,5742,7602,1682,1071,2821,7802,2341,6062,3832,0692,1852,3941,4551,5491,9221,4941,7750000000
       Other Current Assets 
0
0
0
0
0
0
0
407
1,570
331
1,939
2,124
2,349
726
436
738
692
533
502
735
1,194
2,183
2,678
1,916
584
1,018
562
1,012
1,212
856
476
405
525
370
191
636
648
1,576
970
1,658
1,592
1,336
700
831
759
1,065
875
838
1,263
779
541
8,649
8,6495417791,2638388751,0657598317001,3361,5921,6589701,5766486361913705254054768561,2121,0125621,0185841,9162,6782,1831,1947355025336927384367262,3492,1241,9393311,5704070000000
   > Long-term Assets 
0
0
1,665
0
-1,739
2,315
3,381
2,945
3,292
3,756
4,174
4,483
4,724
4,878
6,997
4,330
4,208
4,047
3,741
3,633
3,631
3,237
3,051
3,022
2,805
2,570
2,688
4,025
3,450
3,258
3,108
2,882
2,439
1,937
2,177
1,899
1,678
1,634
1,371
1,119
1,197
2,557
9,866
9,507
9,266
8,821
8,710
8,441
8,342
8,143
7,809
7,242
7,2427,8098,1438,3428,4418,7108,8219,2669,5079,8662,5571,1971,1191,3711,6341,6781,8992,1771,9372,4392,8823,1083,2583,4504,0252,6882,5702,8053,0223,0513,2373,6313,6333,7414,0474,2084,3306,9974,8784,7244,4834,1743,7563,2922,9453,3812,315-1,73901,66500
       Property Plant Equipment 
0
0
1,665
0
0
1,422
1,575
1,764
1,840
1,957
2,102
2,183
2,154
2,399
2,625
2,617
2,579
2,561
2,435
2,458
2,562
2,301
2,249
2,350
2,271
2,170
2,365
3,696
3,093
2,897
2,741
2,511
2,133
1,819
1,857
1,664
1,515
1,509
1,207
978
1,069
2,333
3,987
3,682
3,450
3,139
2,995
2,755
2,737
2,519
2,365
2,137
2,1372,3652,5192,7372,7552,9953,1393,4503,6823,9872,3331,0699781,2071,5091,5151,6641,8571,8192,1332,5112,7412,8973,0933,6962,3652,1702,2712,3502,2492,3012,5622,4582,4352,5612,5792,6172,6252,3992,1542,1832,1021,9571,8401,7641,5751,422001,66500
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
0
0
0
0
0
0
0
0
0
431
431
431
431
431
431
431
431
431
431
43143143143143143143143143143100000000018918918918918918918918918918918918918918918918918918918900000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
55
0
0
0
1,584
1,431
1,297
1,162
1,026
894
762
626
491
359
225
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,217
5,136
5,053
4,972
4,892
4,815
4,739
4,662
4,580
4,317
4,3174,5804,6624,7394,8154,8924,9725,0535,1365,2170000000000000000902253594916267628941,0261,1621,2971,4311,584000550000000000
       Other Assets 
0
0
-1,665
0
1,739
-2,315
-3,381
1,181
1,451
1,799
2,072
2,300
2,570
2,479
4,372
1,713
1,629
1,486
1,306
1,175
1,069
936
802
124
120
121
134
140
168
172
178
182
117
118
1,005
235
163
125
164
141
128
224
231
0
332
279
0
0
0
0
0
0
00000027933202312241281411641251632351,0051181171821781721681401341211201248029361,0691,1751,3061,4861,6291,7134,3722,4792,5702,3002,0721,7991,4511,181-3,381-2,3151,7390-1,66500
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000002,50200000000000000
> Total Liabilities 
10
19
19
14
10
10
16
96,337
36,706
21,340
10,674
10,936
12,971
12,880
23,390
15,798
12,014
13,393
17,894
18,278
17,304
13,738
16,597
16,120
15,582
16,836
14,927
16,326
20,179
13,871
15,118
11,716
22,377
15,085
16,163
15,529
12,877
11,671
11,947
10,756
8,791
10,697
15,461
15,821
16,179
15,926
16,312
14,906
14,925
14,339
13,945
14,618
14,61813,94514,33914,92514,90616,31215,92616,17915,82115,46110,6978,79110,75611,94711,67112,87715,52916,16315,08522,37711,71615,11813,87120,17916,32614,92716,83615,58216,12016,59713,73817,30418,27817,89413,39312,01415,79823,39012,88012,97110,93610,67421,34036,70696,33716101014191910
   > Total Current Liabilities 
10
19
19
14
10
10
16
5,613
6,105
5,896
6,614
6,708
8,357
8,256
8,619
7,849
5,792
5,506
6,314
7,021
6,587
6,592
9,165
10,028
9,395
10,185
10,132
9,710
9,343
8,087
7,832
7,550
7,129
5,233
4,974
5,981
4,681
4,675
6,855
5,970
4,819
7,858
9,201
9,537
10,129
7,834
8,117
7,312
7,704
7,506
7,537
8,553
8,5537,5377,5067,7047,3128,1177,83410,1299,5379,2017,8584,8195,9706,8554,6754,6815,9814,9745,2337,1297,5507,8328,0879,3439,71010,13210,1859,39510,0289,1656,5926,5877,0216,3145,5065,7927,8498,6198,2568,3576,7086,6145,8966,1055,61316101014191910
       Short-term Debt 
0
0
18
9
9
9
11
39
40
41
82
42
43
79
80
81
78
67
54
432
972
1,556
2,173
2,367
2,368
2,368
2,368
2,775
2,762
2,768
2,754
2,604
2,702
406
548
1,361
514
744
458
194
102
488
2,992
2,972
3,653
1,952
1,976
1,622
860
1,684
1,677
1,675
1,6751,6771,6848601,6221,9761,9523,6532,9722,9924881021944587445141,3615484062,7022,6042,7542,7682,7622,7752,3682,3682,3682,3672,1731,556972432546778818079434282414039119991800
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
41
0
0
0
80
0
0
0
6,843
432
972
1,556
2,139
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,170
2,433
0
0
814
0
0
0
0
0
1,996
2,310
2,623
2,937
1,250
1,250
1,250
1,250
1,250
1,250
1,250
1,2501,2501,2501,2501,2501,2501,2502,9372,6232,3101,99600000814002,4332,1702,3332,3332,3332,3332,3332,3332,3332,3332,1391,5569724326,84300080000410000000000
       Accounts payable 
0
0
1,730
0
0
1,920
4
1,044
1,227
1,077
783
1,464
2,306
2,148
2,694
3,618
2,074
1,359
1,879
2,867
2,068
990
2,420
3,392
2,590
3,438
3,156
2,474
2,480
1,362
1,903
1,999
1,902
1,813
1,501
1,652
1,428
1,308
3,107
2,939
2,045
2,387
3,151
3,042
3,155
2,502
1,847
1,876
2,125
1,808
1,552
1,999
1,9991,5521,8082,1251,8761,8472,5023,1553,0423,1512,3872,0452,9393,1071,3081,4281,6521,5011,8131,9021,9991,9031,3622,4802,4743,1563,4382,5903,3922,4209902,0682,8671,8791,3592,0743,6182,6942,1482,3061,4647831,0771,2271,04441,920001,73000
       Other Current Liabilities 
10
19
-1,729
0
1
-1,919
1
1,570
1,224
1,323
2,291
1,616
1,934
2,190
1,885
2,928
2,930
2,982
3,556
2,747
2,599
2,804
4,088
3,653
3,127
3,434
3,506
3,250
2,732
3,302
2,268
1,716
1,180
1,566
1,429
1,475
1,317
1,149
2,125
1,924
1,774
6,026
2,031
2,715
2,271
1,948
2,544
2,297
4,127
1,975
2,352
2,966
2,9662,3521,9754,1272,2972,5441,9482,2712,7152,0316,0261,7741,9242,1251,1491,3171,4751,4291,5661,1801,7162,2683,3022,7323,2503,5063,4343,1273,6534,0882,8042,5992,7473,5562,9822,9302,9281,8852,1901,9341,6162,2911,3231,2241,5701-1,91910-1,7291910
   > Long-term Liabilities 
0
0
18
0
9
9
15
90,724
30,601
15,444
4,060
4,228
4,614
4,624
14,771
7,949
6,222
7,887
11,580
11,257
10,717
7,146
7,432
6,092
6,187
6,651
4,795
6,616
10,836
5,784
7,286
4,166
15,248
9,852
11,189
9,548
8,196
6,996
5,092
4,786
3,972
2,839
6,260
6,284
6,050
8,092
8,195
7,594
7,221
6,833
6,408
6,065
6,0656,4086,8337,2217,5948,1958,0926,0506,2846,2602,8393,9724,7865,0926,9968,1969,54811,1899,85215,2484,1667,2865,78410,8366,6164,7956,6516,1876,0927,4327,14610,71711,25711,5807,8876,2227,94914,7714,6244,6144,2284,06015,44430,60190,724159901800
       Long term Debt Total 
0
0
0
0
0
0
0
88,162
0
11,908
77
0
0
225
9,195
6,210
4,545
6,165
10,335
0
0
0
0
0
4,874
3,199
2,648
2,105
1,538
972
407
1,788
13,005
7,639
9,112
7,763
6,617
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000006,6177,7639,1127,63913,0051,7884079721,5382,1052,6483,1994,8740000010,3356,1654,5456,2109,195225007711,908088,1620000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000002,50200000000000000
       Other Liabilities 
0
0
0
0
0
0
0
90,613
30,502
15,356
3,983
4,163
4,561
4,624
14,625
7,824
6,114
7,788
4,701
4,730
4,738
1,713
2,546
1,755
2,406
3,425
2,147
3,505
8,364
3,994
6,168
3,571
14,096
6,400
7,881
7,187
6,205
5,004
3,099
2,792
1,863
1,672
0
0
1,842
2,209
0
0
0
0
0
0
0000002,2091,842001,6721,8632,7923,0995,0046,2057,1877,8816,40014,0963,5716,1683,9948,3643,5052,1473,4252,4061,7552,5461,7134,7384,7304,7017,7886,1147,82414,6254,6244,5614,1633,98315,35630,50290,6130000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
2,562
0
3,536
3,983
0
0
4,399
4,613
766
747
822
805
776
653
685
816
766
1,201
1,535
0
36
36
36
36
66
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000663636363601,5351,2017668166856537768058227477664,6134,399003,9833,53602,5620000000
> Total Stockholder Equity
-5
-6
11
0
-8
-10
-16
-74,536
-18,109
-5,922
22,800
19,097
13,935
9,246
8,808
6,753
1,561
8,228
6,531
-1,383
1,628
29,667
21,391
14,839
7,626
5,587
2,728
4,534
5,404
6,421
6,797
5,228
-28
8,401
4,434
40,975
40,096
39,062
37,219
33,486
31,729
28,614
25,442
21,283
17,807
15,257
12,606
14,051
12,059
14,870
12,707
12,692
12,69212,70714,87012,05914,05112,60615,25717,80721,28325,44228,61431,72933,48637,21939,06240,09640,9754,4348,401-285,2286,7976,4215,4044,5342,7285,5877,62614,83921,39129,6671,628-1,3836,5318,2281,5616,7538,8089,24613,93519,09722,800-5,922-18,109-74,536-16-10-8011-6-5
   Common Stock
5
5
6
0
6
6
6
78
79
79
102
102
102
102
105
109
16
21
22
22
26
60
60
60
61
63
63
68
75
75
87
6
8
8
8
13
13
13
13
13
13
13
13
13
14
14
15
18
19
22
22
28
282222191815141413131313131313131388868775756863636160606026222221161091051021021021027979786660655
   Retained Earnings -253,592-250,475-247,062-244,990-242,574-239,145-235,931-232,566-228,336-223,947-220,769-216,465-213,487-208,867-206,004-204,046-202,773-199,103-195,127-197,579-185,812-183,278-180,557-180,763-177,697-171,146-167,014-160,031-152,055-144,154-135,176-128,841-123,334-114,861-109,284-100,806-95,042-91,391-86,746-81,561-75,916-71,801-51,646-63,670-119,797-48-42-40-17-13-11-10
   Capital Surplus 
0
0
0
0
0
0
26
45,183
0
45,645
94,499
0
0
95,890
100,094
101,686
102,341
117,498
121,291
121,880
130,598
165,060
165,825
167,381
167,823
172,721
173,903
182,107
186,142
186,629
189,938
190,811
197,513
203,905
204,376
244,117
244,636
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000244,636244,117204,376203,905197,513190,811189,938186,629186,142182,107173,903172,721167,823167,381165,825165,060130,598121,880121,291117,498102,341101,686100,09495,8900094,49945,645045,18326000000
   Treasury Stock0000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
18
0
26
32
26
45,183
45,483
45,645
94,499
94,911
95,394
95,890
100,094
101,686
102,341
117,498
121,291
121,880
130,598
165,060
165,825
167,381
167,823
172,721
173,903
182,107
186,142
186,629
189,938
190,811
197,513
203,905
204,376
244,117
244,636
245,299
246,090
246,765
247,347
247,884
248,813
249,237
250,000
250,441
251,580
256,160
256,491
261,898
262,203
265,832
265,832262,203261,898256,491256,160251,580250,441250,000249,237248,813247,884247,347246,765246,090245,299244,636244,117204,376203,905197,513190,811189,938186,629186,142182,107173,903172,721167,823167,381165,825165,060130,598121,880121,291117,498102,341101,686100,09495,89095,39494,91194,49945,64545,48345,18326322601800



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue17,925
Cost of Revenue-8,414
Gross Profit9,5119,511
 
Operating Income (+$)
Gross Profit9,511
Operating Expense-19,971
Operating Income-10,460-10,460
 
Operating Expense (+$)
Research Development3,874
Selling General Administrative8,789
Selling And Marketing Expenses7,308
Operating Expense19,97119,971
 
Net Interest Income (+$)
Interest Income0
Interest Expense-269
Other Finance Cost-0
Net Interest Income-269
 
Pretax Income (+$)
Operating Income-10,460
Net Interest Income-269
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-11,330-9,590
EBIT - interestExpense = -11,330
-11,330
-11,061
Interest Expense269
Earnings Before Interest and Taxes (EBIT)-11,061-11,061
Earnings Before Interest and Taxes (EBITDA)-9,453
 
After tax Income (+$)
Income Before Tax-11,330
Tax Provision-0
Net Income From Continuing Ops-11,330-11,330
Net Income-11,330
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses28,385
Total Other Income/Expenses Net-870269
 

Technical Analysis of Ekso Bionics Holdings Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ekso Bionics Holdings Inc. The general trend of Ekso Bionics Holdings Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ekso Bionics Holdings Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Ekso Bionics Holdings Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ekso Bionics Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.4635 < 4.99 < 5.157.

The bearish price targets are: 2.73.

Know someone who trades $EKSO? Share this with them.πŸ‘‡

Ekso Bionics Holdings Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ekso Bionics Holdings Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ekso Bionics Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ekso Bionics Holdings Inc. The current macd is -0.29055153.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ekso Bionics Holdings Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ekso Bionics Holdings Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ekso Bionics Holdings Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ekso Bionics Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartEkso Bionics Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ekso Bionics Holdings Inc. The current adx is 11.45.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ekso Bionics Holdings Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Ekso Bionics Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ekso Bionics Holdings Inc. The current sar is 2.86505646.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ekso Bionics Holdings Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ekso Bionics Holdings Inc. The current rsi is 41.17. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Ekso Bionics Holdings Inc Daily Relative Strength Index (RSI) ChartEkso Bionics Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ekso Bionics Holdings Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ekso Bionics Holdings Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ekso Bionics Holdings Inc Daily Stochastic Oscillator ChartEkso Bionics Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ekso Bionics Holdings Inc. The current cci is -17.70041206.

Ekso Bionics Holdings Inc Daily Commodity Channel Index (CCI) ChartEkso Bionics Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ekso Bionics Holdings Inc. The current cmo is -11.46295169.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ekso Bionics Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartEkso Bionics Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ekso Bionics Holdings Inc. The current willr is -39.25233645.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ekso Bionics Holdings Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ekso Bionics Holdings Inc Daily Williams %R ChartEkso Bionics Holdings Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ekso Bionics Holdings Inc. The current atr is 0.38362119.

Ekso Bionics Holdings Inc Daily Average True Range (ATR) ChartEkso Bionics Holdings Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ekso Bionics Holdings Inc. The current obv is -7,979,967.

Ekso Bionics Holdings Inc Daily On-Balance Volume (OBV) ChartEkso Bionics Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ekso Bionics Holdings Inc. The current mfi is 62.36.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ekso Bionics Holdings Inc Daily Money Flow Index (MFI) ChartEkso Bionics Holdings Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ekso Bionics Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Ekso Bionics Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ekso Bionics Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.175
Ma 20Greater thanMa 503.424
Ma 50Greater thanMa 1004.574
Ma 100Greater thanMa 2005.625
OpenGreater thanClose3.410
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ekso Bionics Holdings Inc with someone you think should read this too:
  • Are you bullish or bearish on Ekso Bionics Holdings Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ekso Bionics Holdings Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ekso Bionics Holdings Inc

I send you an email if I find something interesting about Ekso Bionics Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ekso Bionics Holdings Inc.

Receive notifications about Ekso Bionics Holdings Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.